Allogene Therapeutics (ALLO) vs Tectonic Therapeutic (TECX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Tectonic Therapeutic (TECX) has outperformed Allogene Therapeutics (ALLO) over the past year, gaining 52.3% versus a gain of 5.9%. Over five years, TECX leads with a -67.4% price change compared with -91.3% for ALLO. Allogene Therapeutics is the larger company by market cap ($494.1 million vs $444.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALLO | TECX |
|---|---|---|
| Share price | $1.43 | $22.71 |
| Market cap | $494.05M | $443.97M |
| 1-day change | -2.05% | +1.34% |
| YTD return | +4.38% | +8.87% |
| 1-year return | +5.93% | +52.31% |
| 5-year return | -91.32% | -67.37% |
| EPS (TTM) | $-0.66 | $-4.57 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.46 | $39.53 |
| 52-week low | $1.04 | $14.81 |
| Distance from 52-week high | -67.94% | -42.55% |
| Average volume | 5.78M | 220.06K |
| Shares outstanding | 345.49M | 19.55M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TECX has outperformed ALLO by 46.4 percentage points over the past year.
ALLO vs TECX FAQ
Which is bigger, Allogene Therapeutics or Tectonic Therapeutic?
Allogene Therapeutics (ALLO) is larger, with a market capitalization of $494.05M compared with $443.97M for Tectonic Therapeutic (TECX).
Which stock has performed better over the past year, ALLO or TECX?
TECX returned +52.31% over the past 12 months, compared with +5.93% for ALLO (price return, excluding dividends). Past performance does not predict future results.
Are Allogene Therapeutics and Tectonic Therapeutic in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.